

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ribosomal small subunit assembly (GO:0000028) | 7.48898298 |
| 2 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.98126542 |
| 3 | viral transcription (GO:0019083) | 5.96208099 |
| 4 | translational termination (GO:0006415) | 5.71849539 |
| 5 | response to peptidoglycan (GO:0032494) | 5.65728685 |
| 6 | definitive hemopoiesis (GO:0060216) | 5.63521969 |
| 7 | DNA deamination (GO:0045006) | 5.39327529 |
| 8 | neutrophil activation involved in immune response (GO:0002283) | 5.24018441 |
| 9 | * negative regulation of erythrocyte differentiation (GO:0045647) | 5.18426316 |
| 10 | platelet dense granule organization (GO:0060155) | 5.08573170 |
| 11 | antigen processing and presentation via MHC class Ib (GO:0002475) | 5.04556315 |
| 12 | translational elongation (GO:0006414) | 4.97611044 |
| 13 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 4.89210718 |
| 14 | cotranslational protein targeting to membrane (GO:0006613) | 4.77202463 |
| 15 | protein targeting to ER (GO:0045047) | 4.74828021 |
| 16 | positive regulation by symbiont of host defense response (GO:0052509) | 4.72101139 |
| 17 | modulation by symbiont of host defense response (GO:0052031) | 4.72101139 |
| 18 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.72101139 |
| 19 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.72101139 |
| 20 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.72101139 |
| 21 | modulation by symbiont of host immune response (GO:0052553) | 4.72101139 |
| 22 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.71704148 |
| 23 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.71704148 |
| 24 | ribosomal small subunit biogenesis (GO:0042274) | 4.62896466 |
| 25 | maturation of SSU-rRNA (GO:0030490) | 4.61721384 |
| 26 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 4.52854756 |
| 27 | protein localization to endoplasmic reticulum (GO:0070972) | 4.51619912 |
| 28 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 4.43647216 |
| 29 | positive regulation of B cell differentiation (GO:0045579) | 4.43077105 |
| 30 | viral life cycle (GO:0019058) | 4.40834938 |
| 31 | megakaryocyte development (GO:0035855) | 4.35012429 |
| 32 | response to interferon-beta (GO:0035456) | 4.24641364 |
| 33 | cellular protein complex disassembly (GO:0043624) | 4.19166235 |
| 34 | lymphoid progenitor cell differentiation (GO:0002320) | 4.18370420 |
| 35 | regulation of mast cell degranulation (GO:0043304) | 4.17998534 |
| 36 | cellular extravasation (GO:0045123) | 4.12883075 |
| 37 | negative regulation of interleukin-12 production (GO:0032695) | 4.11878019 |
| 38 | endosome to pigment granule transport (GO:0043485) | 4.11655094 |
| 39 | endosome to melanosome transport (GO:0035646) | 4.11655094 |
| 40 | microglial cell activation (GO:0001774) | 4.08693924 |
| 41 | response to muramyl dipeptide (GO:0032495) | 4.05533491 |
| 42 | regulation of gamma-delta T cell activation (GO:0046643) | 4.04917210 |
| 43 | detection of other organism (GO:0098543) | 4.04745411 |
| 44 | translational initiation (GO:0006413) | 3.98557083 |
| 45 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.95128032 |
| 46 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.94915994 |
| 47 | macrophage activation involved in immune response (GO:0002281) | 3.93342616 |
| 48 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.89558537 |
| 49 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.85841890 |
| 50 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.85759024 |
| 51 | negative regulation of cell killing (GO:0031342) | 3.85759024 |
| 52 | detection of bacterium (GO:0016045) | 3.81316443 |
| 53 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.79116027 |
| 54 | protein complex disassembly (GO:0043241) | 3.76625331 |
| 55 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.74769244 |
| 56 | response to interferon-alpha (GO:0035455) | 3.71625113 |
| 57 | B cell receptor signaling pathway (GO:0050853) | 3.70168714 |
| 58 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.68897984 |
| 59 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.67075087 |
| 60 | response to host immune response (GO:0052572) | 3.67075087 |
| 61 | regulation of leukocyte degranulation (GO:0043300) | 3.66162592 |
| 62 | positive regulation of mast cell activation (GO:0033005) | 3.64687731 |
| 63 | mature B cell differentiation involved in immune response (GO:0002313) | 3.61792969 |
| 64 | positive regulation of mast cell degranulation (GO:0043306) | 3.58993722 |
| 65 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.58993722 |
| 66 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.56503346 |
| 67 | macrophage activation (GO:0042116) | 3.56149800 |
| 68 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.55917157 |
| 69 | germinal center formation (GO:0002467) | 3.51935110 |
| 70 | endothelium development (GO:0003158) | 3.51036379 |
| 71 | macromolecular complex disassembly (GO:0032984) | 3.50708980 |
| 72 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.48641014 |
| 73 | secretory granule organization (GO:0033363) | 3.47251528 |
| 74 | myeloid cell activation involved in immune response (GO:0002275) | 3.47115877 |
| 75 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 3.44257862 |
| 76 | neutrophil activation (GO:0042119) | 3.42745765 |
| 77 | regulation of mast cell activation (GO:0033003) | 3.41690175 |
| 78 | DNA strand elongation (GO:0022616) | 3.38233500 |
| 79 | detection of external biotic stimulus (GO:0098581) | 3.32541982 |
| 80 | mRNA catabolic process (GO:0006402) | 3.31510708 |
| 81 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.29600298 |
| 82 | regulation of B cell differentiation (GO:0045577) | 3.22781455 |
| 83 | granulocyte activation (GO:0036230) | 3.22539181 |
| 84 | telomere maintenance via recombination (GO:0000722) | 3.21875217 |
| 85 | response to host (GO:0075136) | 3.21759659 |
| 86 | response to host defenses (GO:0052200) | 3.21759659 |
| 87 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.21759659 |
| 88 | RNA catabolic process (GO:0006401) | 3.14642544 |
| 89 | histamine secretion (GO:0001821) | 3.13968112 |
| 90 | defense response to protozoan (GO:0042832) | 3.13661617 |
| 91 | protein targeting to membrane (GO:0006612) | 3.11461366 |
| 92 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.11377531 |
| 93 | regulation of regulated secretory pathway (GO:1903305) | 3.10136534 |
| 94 | pseudouridine synthesis (GO:0001522) | 3.10081607 |
| 95 | polyketide metabolic process (GO:0030638) | 3.09270390 |
| 96 | doxorubicin metabolic process (GO:0044598) | 3.09270390 |
| 97 | daunorubicin metabolic process (GO:0044597) | 3.09270390 |
| 98 | purine-containing compound salvage (GO:0043101) | 3.09104204 |
| 99 | ribosomal large subunit biogenesis (GO:0042273) | 3.08962333 |
| 100 | detection of molecule of bacterial origin (GO:0032490) | 3.08259141 |
| 101 | negative regulation of bone mineralization (GO:0030502) | 3.07618282 |
| 102 | T cell homeostasis (GO:0043029) | 3.07478802 |
| 103 | leukocyte degranulation (GO:0043299) | 3.05689996 |
| 104 | erythrocyte maturation (GO:0043249) | 3.05435551 |
| 105 | neutrophil mediated immunity (GO:0002446) | 3.05285608 |
| 106 | positive regulation of granulocyte differentiation (GO:0030854) | 3.04817417 |
| 107 | negative regulation of T cell mediated immunity (GO:0002710) | 3.04638005 |
| 108 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.03602972 |
| 109 | detection of biotic stimulus (GO:0009595) | 3.01259050 |
| 110 | response to protozoan (GO:0001562) | 3.00679126 |
| 111 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.97624336 |
| 112 | leukocyte aggregation (GO:0070486) | 2.96817330 |
| 113 | lymph node development (GO:0048535) | 2.96663157 |
| 114 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.95651194 |
| 115 | immunoglobulin mediated immune response (GO:0016064) | 2.94318364 |
| 116 | negative regulation of granulocyte differentiation (GO:0030853) | 2.94005522 |
| 117 | regulation of granulocyte differentiation (GO:0030852) | 2.93902503 |
| 118 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.93326358 |
| 119 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.92448914 |
| 120 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.89960952 |
| 121 | mature B cell differentiation (GO:0002335) | 2.89511817 |
| 122 | granulocyte differentiation (GO:0030851) | 2.89382187 |
| 123 | Peyers patch development (GO:0048541) | 2.87062260 |
| 124 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.87062260 |
| 125 | DNA replication initiation (GO:0006270) | 2.82886125 |
| 126 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.82683158 |
| 127 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.82532687 |
| 128 | positive thymic T cell selection (GO:0045059) | 2.82261803 |
| 129 | mast cell activation (GO:0045576) | 2.81741275 |
| 130 | respiratory burst (GO:0045730) | 2.81036923 |
| 131 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.80054289 |
| 132 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.79903600 |
| 133 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.78663446 |
| 134 | negative regulation of interleukin-6 production (GO:0032715) | 2.78261975 |
| 135 | mitotic recombination (GO:0006312) | 2.77447416 |
| 136 | respiratory chain complex IV assembly (GO:0008535) | 2.76993919 |
| 137 | * regulation of erythrocyte differentiation (GO:0045646) | 2.76478620 |
| 138 | necroptotic process (GO:0070266) | 2.76050917 |
| 139 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.75814670 |
| 140 | positive regulation of interferon-alpha production (GO:0032727) | 2.75020267 |
| 141 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.74938513 |
| 142 | translation (GO:0006412) | 2.74298665 |
| 143 | negative regulation of viral entry into host cell (GO:0046597) | 2.73987832 |
| 144 | regulation of interferon-alpha production (GO:0032647) | 2.73671543 |
| 145 | N-acetylneuraminate metabolic process (GO:0006054) | 2.73626664 |
| 146 | B cell mediated immunity (GO:0019724) | 2.72339379 |
| 147 | telomere maintenance via telomere lengthening (GO:0010833) | 2.72314900 |
| 148 | negative regulation of viral genome replication (GO:0045071) | 2.72258990 |
| 149 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.71489128 |
| 150 | positive regulation of tumor necrosis factor production (GO:0032760) | 2.70933673 |
| 151 | angiogenesis involved in wound healing (GO:0060055) | 2.70283856 |
| 152 | positive regulation of regulated secretory pathway (GO:1903307) | 2.68710932 |
| 153 | regulation of macrophage cytokine production (GO:0010935) | 2.68608068 |
| 154 | L-fucose catabolic process (GO:0042355) | 2.68398107 |
| 155 | fucose catabolic process (GO:0019317) | 2.68398107 |
| 156 | L-fucose metabolic process (GO:0042354) | 2.68398107 |
| 157 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.66929886 |
| 158 | positive regulation of leukocyte degranulation (GO:0043302) | 2.65462591 |
| 159 | cellular response to type I interferon (GO:0071357) | 2.65191165 |
| 160 | type I interferon signaling pathway (GO:0060337) | 2.65191165 |
| 161 | tRNA methylation (GO:0030488) | 2.65058092 |
| 162 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 2.64977748 |
| 163 | response to type I interferon (GO:0034340) | 2.64491619 |
| 164 | negative regulation of interleukin-17 production (GO:0032700) | 2.64066323 |
| 165 | iron-sulfur cluster assembly (GO:0016226) | 2.62884129 |
| 166 | metallo-sulfur cluster assembly (GO:0031163) | 2.62884129 |
| 167 | regulation of hypersensitivity (GO:0002883) | 2.62535320 |
| 168 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.60186033 |
| 169 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.59595398 |
| 170 | heparin biosynthetic process (GO:0030210) | 2.58643260 |
| 171 | heparin metabolic process (GO:0030202) | 2.58643260 |
| 172 | myeloid cell development (GO:0061515) | 2.57867258 |
| 173 | DNA unwinding involved in DNA replication (GO:0006268) | 2.56807466 |
| 174 | negative regulation of biomineral tissue development (GO:0070168) | 2.56587499 |
| 175 | mast cell activation involved in immune response (GO:0002279) | 2.56318372 |
| 176 | mast cell degranulation (GO:0043303) | 2.56318372 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.59596897 |
| 2 | SCL_19346495_ChIP-Seq_HPC-7_Human | 4.34731829 |
| 3 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.63007926 |
| 4 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.06434222 |
| 5 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.05630768 |
| 6 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 3.03657245 |
| 7 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.98848660 |
| 8 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.92453634 |
| 9 | * IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.90836969 |
| 10 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.79111899 |
| 11 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.67460598 |
| 12 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.66506696 |
| 13 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.62986966 |
| 14 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.55161371 |
| 15 | GATA1_22025678_ChIP-Seq_K562_Human | 2.52875711 |
| 16 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.50636942 |
| 17 | * VDR_21846776_ChIP-Seq_THP-1_Human | 2.43692870 |
| 18 | MYC_22102868_ChIP-Seq_BL_Human | 2.43127258 |
| 19 | * GATA1_19941826_ChIP-Seq_K562_Human | 2.35574562 |
| 20 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.32183661 |
| 21 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.25484350 |
| 22 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 2.21859343 |
| 23 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.19981122 |
| 24 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.17017465 |
| 25 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.13422437 |
| 26 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.09405297 |
| 27 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.08739768 |
| 28 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.01832089 |
| 29 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.01516858 |
| 30 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.95845334 |
| 31 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.93146644 |
| 32 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.91536488 |
| 33 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.91403345 |
| 34 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.91181469 |
| 35 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.90971675 |
| 36 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.89972873 |
| 37 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.88703505 |
| 38 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.87504854 |
| 39 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.85736086 |
| 40 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.81740667 |
| 41 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.81450471 |
| 42 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.81151277 |
| 43 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.80295241 |
| 44 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.78751927 |
| 45 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.78350714 |
| 46 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.77850625 |
| 47 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.77250267 |
| 48 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.75468828 |
| 49 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.74955220 |
| 50 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.74330502 |
| 51 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.74082779 |
| 52 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.71729670 |
| 53 | * VDR_24787735_ChIP-Seq_THP-1_Human | 1.68470671 |
| 54 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.67792855 |
| 55 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.67606061 |
| 56 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.67175239 |
| 57 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.66666632 |
| 58 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.66289417 |
| 59 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.64407145 |
| 60 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.64319084 |
| 61 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.64298299 |
| 62 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.63576352 |
| 63 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.62985828 |
| 64 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.61307982 |
| 65 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.61199259 |
| 66 | MAF_26560356_Chip-Seq_TH1_Human | 1.60373268 |
| 67 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.58278030 |
| 68 | MYB_26560356_Chip-Seq_TH2_Human | 1.55917101 |
| 69 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.53017907 |
| 70 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.52064665 |
| 71 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.51444483 |
| 72 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.47797176 |
| 73 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.47491887 |
| 74 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.46931811 |
| 75 | MYB_26560356_Chip-Seq_TH1_Human | 1.45800463 |
| 76 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.45332785 |
| 77 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.44332210 |
| 78 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.43069662 |
| 79 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.41969964 |
| 80 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.41888236 |
| 81 | UTX_26944678_Chip-Seq_JUKART_Human | 1.41579098 |
| 82 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.40916711 |
| 83 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.39091192 |
| 84 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.38765914 |
| 85 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.36853389 |
| 86 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.34469580 |
| 87 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.32865737 |
| 88 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.31087335 |
| 89 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.31066457 |
| 90 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.30428448 |
| 91 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.30311943 |
| 92 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.29766005 |
| 93 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.29012000 |
| 94 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.28628384 |
| 95 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.27493663 |
| 96 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.25913094 |
| 97 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.25510040 |
| 98 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.24740338 |
| 99 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.24543113 |
| 100 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.23132003 |
| 101 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.22452850 |
| 102 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.22123433 |
| 103 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.21645176 |
| 104 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.21492543 |
| 105 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.20963300 |
| 106 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.19361061 |
| 107 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.19142542 |
| 108 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.16961925 |
| 109 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.15652598 |
| 110 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.15128060 |
| 111 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.13785914 |
| 112 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.13122936 |
| 113 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.12569877 |
| 114 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.11053685 |
| 115 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.10495704 |
| 116 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.08617871 |
| 117 | SPI1_23127762_ChIP-Seq_K562_Human | 1.08360562 |
| 118 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.07953059 |
| 119 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.07374756 |
| 120 | MAF_26560356_Chip-Seq_TH2_Human | 1.07345051 |
| 121 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.05293525 |
| 122 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.04759466 |
| 123 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.02969397 |
| 124 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.02717784 |
| 125 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.02338160 |
| 126 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.01718323 |
| 127 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.00128921 |
| 128 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.99705858 |
| 129 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.99566709 |
| 130 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.99168078 |
| 131 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.97315057 |
| 132 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.96308609 |
| 133 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.95452417 |
| 134 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.95134014 |
| 135 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.94636885 |
| 136 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 0.93804136 |
| 137 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.93766844 |
| 138 | GATA3_26560356_Chip-Seq_TH2_Human | 0.93328174 |
| 139 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 0.88789568 |
| 140 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.88781084 |
| 141 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.88572320 |
| 142 | * THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.88463101 |
| 143 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.87737794 |
| 144 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.87681438 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 4.41545588 |
| 2 | MP0002396_abnormal_hematopoietic_system | 4.25029473 |
| 3 | MP0001835_abnormal_antigen_presentation | 3.36874783 |
| 4 | MP0004147_increased_porphyrin_level | 3.34427828 |
| 5 | MP0005174_abnormal_tail_pigmentation | 3.32218820 |
| 6 | MP0001545_abnormal_hematopoietic_system | 3.16058342 |
| 7 | MP0005397_hematopoietic_system_phenotyp | 3.16058342 |
| 8 | MP0005075_abnormal_melanosome_morpholog | 3.13194589 |
| 9 | MP0004808_abnormal_hematopoietic_stem | 3.10294367 |
| 10 | MP0000685_abnormal_immune_system | 2.88391330 |
| 11 | MP0005464_abnormal_platelet_physiology | 2.84009089 |
| 12 | MP0009785_altered_susceptibility_to | 2.69946232 |
| 13 | MP0000465_gastrointestinal_hemorrhage | 2.62317668 |
| 14 | MP0005671_abnormal_response_to | 2.52875916 |
| 15 | MP0000490_abnormal_crypts_of | 2.30616656 |
| 16 | * MP0002398_abnormal_bone_marrow | 2.25798665 |
| 17 | MP0005025_abnormal_response_to | 2.22327688 |
| 18 | MP0003656_abnormal_erythrocyte_physiolo | 2.20897295 |
| 19 | MP0002095_abnormal_skin_pigmentation | 2.20765593 |
| 20 | * MP0000689_abnormal_spleen_morphology | 2.01907483 |
| 21 | MP0001800_abnormal_humoral_immune | 2.01471389 |
| 22 | MP0009379_abnormal_foot_pigmentation | 2.00093450 |
| 23 | MP0002452_abnormal_antigen_presenting | 1.99425200 |
| 24 | MP0009278_abnormal_bone_marrow | 1.95190161 |
| 25 | MP0002420_abnormal_adaptive_immunity | 1.93597942 |
| 26 | MP0003763_abnormal_thymus_physiology | 1.92803022 |
| 27 | MP0001819_abnormal_immune_cell | 1.91367925 |
| 28 | MP0003724_increased_susceptibility_to | 1.91320086 |
| 29 | MP0002723_abnormal_immune_serum | 1.91242933 |
| 30 | MP0002166_altered_tumor_susceptibility | 1.90845382 |
| 31 | MP0009333_abnormal_splenocyte_physiolog | 1.88260191 |
| 32 | MP0003693_abnormal_embryo_hatching | 1.87946232 |
| 33 | MP0000015_abnormal_ear_pigmentation | 1.87834011 |
| 34 | * MP0002722_abnormal_immune_system | 1.85982876 |
| 35 | MP0001873_stomach_inflammation | 1.82440443 |
| 36 | * MP0000716_abnormal_immune_system | 1.82383826 |
| 37 | MP0001853_heart_inflammation | 1.81791904 |
| 38 | MP0002419_abnormal_innate_immunity | 1.78661776 |
| 39 | * MP0002429_abnormal_blood_cell | 1.78622410 |
| 40 | MP0005000_abnormal_immune_tolerance | 1.75565974 |
| 41 | MP0006054_spinal_hemorrhage | 1.75373652 |
| 42 | MP0002148_abnormal_hypersensitivity_rea | 1.74977373 |
| 43 | MP0010155_abnormal_intestine_physiology | 1.74505156 |
| 44 | MP0003436_decreased_susceptibility_to | 1.71864807 |
| 45 | MP0003866_abnormal_defecation | 1.68911787 |
| 46 | MP0010094_abnormal_chromosome_stability | 1.65344419 |
| 47 | MP0003075_altered_response_to | 1.62190635 |
| 48 | MP0001986_abnormal_taste_sensitivity | 1.60009521 |
| 49 | MP0008058_abnormal_DNA_repair | 1.58610638 |
| 50 | MP0008007_abnormal_cellular_replicative | 1.58126066 |
| 51 | MP0008057_abnormal_DNA_replication | 1.47275524 |
| 52 | MP0005387_immune_system_phenotype | 1.45920285 |
| 53 | MP0001790_abnormal_immune_system | 1.45920285 |
| 54 | MP0000703_abnormal_thymus_morphology | 1.40223823 |
| 55 | MP0005167_abnormal_blood-brain_barrier | 1.39673018 |
| 56 | MP0003077_abnormal_cell_cycle | 1.35549043 |
| 57 | MP0003172_abnormal_lysosome_physiology | 1.32448792 |
| 58 | MP0002405_respiratory_system_inflammati | 1.30807706 |
| 59 | MP0002006_tumorigenesis | 1.30257193 |
| 60 | MP0003690_abnormal_glial_cell | 1.29449793 |
| 61 | MP0005451_abnormal_body_composition | 1.29106694 |
| 62 | MP0008004_abnormal_stomach_pH | 1.28732330 |
| 63 | MP0003943_abnormal_hepatobiliary_system | 1.28292484 |
| 64 | MP0001845_abnormal_inflammatory_respons | 1.24091208 |
| 65 | MP0001851_eye_inflammation | 1.22540242 |
| 66 | MP0008469_abnormal_protein_level | 1.15590037 |
| 67 | * MP0002019_abnormal_tumor_incidence | 1.11111395 |
| 68 | MP0004510_myositis | 1.09994917 |
| 69 | MP0008260_abnormal_autophagy | 1.09986420 |
| 70 | MP0004957_abnormal_blastocyst_morpholog | 1.09488468 |
| 71 | MP0000372_irregular_coat_pigmentation | 1.08138426 |
| 72 | MP0004883_abnormal_blood_vessel | 1.04983460 |
| 73 | MP0006036_abnormal_mitochondrial_physio | 1.04357023 |
| 74 | MP0003828_pulmonary_edema | 1.04102374 |
| 75 | MP0003191_abnormal_cellular_cholesterol | 1.03615202 |
| 76 | MP0000604_amyloidosis | 1.02888953 |
| 77 | MP0003111_abnormal_nucleus_morphology | 1.02726259 |
| 78 | MP0002998_abnormal_bone_remodeling | 1.02436398 |
| 79 | MP0005083_abnormal_biliary_tract | 1.02236852 |
| 80 | MP0003183_abnormal_peptide_metabolism | 1.02006022 |
| 81 | MP0005166_decreased_susceptibility_to | 1.00340391 |
| 82 | MP0001188_hyperpigmentation | 0.99112366 |
| 83 | MP0000681_abnormal_thyroid_gland | 0.98549837 |
| 84 | MP0002132_abnormal_respiratory_system | 0.98220485 |
| 85 | * MP0000313_abnormal_cell_death | 0.96869826 |
| 86 | MP0003567_abnormal_fetal_cardiomyocyte | 0.94886234 |
| 87 | MP0006292_abnormal_olfactory_placode | 0.93085177 |
| 88 | MP0000343_altered_response_to | 0.91385091 |
| 89 | MP0005164_abnormal_response_to | 0.90880566 |
| 90 | MP0002877_abnormal_melanocyte_morpholog | 0.89237468 |
| 91 | MP0010368_abnormal_lymphatic_system | 0.88943225 |
| 92 | MP0001348_abnormal_lacrimal_gland | 0.88111221 |
| 93 | MP0003186_abnormal_redox_activity | 0.85574182 |
| 94 | MP0003806_abnormal_nucleotide_metabolis | 0.85159543 |
| 95 | MP0005535_abnormal_body_temperature | 0.84738898 |
| 96 | MP0002009_preneoplasia | 0.83249105 |
| 97 | MP0002075_abnormal_coat/hair_pigmentati | 0.81454675 |
| 98 | MP0000249_abnormal_blood_vessel | 0.81197621 |
| 99 | MP0005409_darkened_coat_color | 0.81106851 |
| 100 | MP0002933_joint_inflammation | 0.81045987 |
| 101 | MP0004130_abnormal_muscle_cell | 0.79233916 |
| 102 | MP0003868_abnormal_feces_composition | 0.76197427 |
| 103 | MP0000477_abnormal_intestine_morphology | 0.76162841 |
| 104 | MP0000371_diluted_coat_color | 0.76042937 |
| 105 | MP0009840_abnormal_foam_cell | 0.74643951 |
| 106 | MP0008874_decreased_physiological_sensi | 0.74266857 |
| 107 | MP0004947_skin_inflammation | 0.72978161 |
| 108 | MP0005310_abnormal_salivary_gland | 0.71395948 |
| 109 | MP0001663_abnormal_digestive_system | 0.71003531 |
| 110 | MP0006082_CNS_inflammation | 0.70183753 |
| 111 | MP0005084_abnormal_gallbladder_morpholo | 0.70021386 |
| 112 | MP0009764_decreased_sensitivity_to | 0.69408657 |
| 113 | MP0005058_abnormal_lysosome_morphology | 0.68979473 |
| 114 | MP0002332_abnormal_exercise_endurance | 0.67282160 |
| 115 | MP0005165_increased_susceptibility_to | 0.66837239 |
| 116 | MP0003786_premature_aging | 0.66759301 |
| 117 | MP0001764_abnormal_homeostasis | 0.65938564 |
| 118 | MP0009697_abnormal_copulation | 0.65287073 |
| 119 | MP0001879_abnormal_lymphatic_vessel | 0.65190278 |
| 120 | MP0005666_abnormal_adipose_tissue | 0.64684130 |
| 121 | MP0003638_abnormal_response/metabolism_ | 0.63781816 |
| 122 | MP0005390_skeleton_phenotype | 0.63599977 |
| 123 | MP0009763_increased_sensitivity_to | 0.63392467 |
| 124 | MP0003300_gastrointestinal_ulcer | 0.61595832 |
| 125 | MP0001533_abnormal_skeleton_physiology | 0.60853012 |
| 126 | MP0003448_altered_tumor_morphology | 0.60006185 |
| 127 | MP0003787_abnormal_imprinting | 0.59791310 |
| 128 | MP0009765_abnormal_xenobiotic_induced | 0.58744087 |
| 129 | * MP0000598_abnormal_liver_morphology | 0.57946496 |
| 130 | MP0000858_altered_metastatic_potential | 0.55598459 |
| 131 | MP0008995_early_reproductive_senescence | 0.54028534 |
| 132 | MP0002928_abnormal_bile_duct | 0.54003681 |
| 133 | MP0004185_abnormal_adipocyte_glucose | 0.53676102 |
| 134 | MP0003795_abnormal_bone_structure | 0.52720988 |
| 135 | MP0003329_amyloid_beta_deposits | 0.52685689 |
| 136 | MP0005319_abnormal_enzyme/_coenzyme | 0.52287559 |
| 137 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.52236617 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Thrombocytosis (HP:0001894) | 5.66892441 |
| 2 | Abnormality of cells of the erythroid lineage (HP:0012130) | 5.58572968 |
| 3 | Abnormal number of erythroid precursors (HP:0012131) | 5.49191602 |
| 4 | Aplastic anemia (HP:0001915) | 5.21967766 |
| 5 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 5.02536024 |
| 6 | Prolonged bleeding time (HP:0003010) | 4.78085094 |
| 7 | Eczematoid dermatitis (HP:0000976) | 4.51234553 |
| 8 | Petechiae (HP:0000967) | 4.47569287 |
| 9 | Chronic otitis media (HP:0000389) | 4.39250918 |
| 10 | IgM deficiency (HP:0002850) | 4.10720865 |
| 11 | Stomatitis (HP:0010280) | 4.06723666 |
| 12 | Obstructive lung disease (HP:0006536) | 3.97265317 |
| 13 | Chronic obstructive pulmonary disease (HP:0006510) | 3.97265317 |
| 14 | Reticulocytopenia (HP:0001896) | 3.92403891 |
| 15 | Reduced antithrombin III activity (HP:0001976) | 3.88000647 |
| 16 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.81690121 |
| 17 | Type I transferrin isoform profile (HP:0003642) | 3.73878463 |
| 18 | Epistaxis (HP:0000421) | 3.67524086 |
| 19 | Myositis (HP:0100614) | 3.65296495 |
| 20 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.62456966 |
| 21 | Polycythemia (HP:0001901) | 3.54926622 |
| 22 | Abnormal platelet function (HP:0011869) | 3.41187776 |
| 23 | Impaired platelet aggregation (HP:0003540) | 3.41187776 |
| 24 | Pallor (HP:0000980) | 3.38983933 |
| 25 | Recurrent cutaneous fungal infections (HP:0011370) | 3.38068195 |
| 26 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.38068195 |
| 27 | Optic neuritis (HP:0100653) | 3.34116869 |
| 28 | Retrobulbar optic neuritis (HP:0100654) | 3.34116869 |
| 29 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 3.08344052 |
| 30 | Abnormal protein N-linked glycosylation (HP:0012347) | 3.08344052 |
| 31 | Abnormal protein glycosylation (HP:0012346) | 3.08344052 |
| 32 | Abnormal glycosylation (HP:0012345) | 3.08344052 |
| 33 | Encephalitis (HP:0002383) | 3.00045482 |
| 34 | Recurrent abscess formation (HP:0002722) | 2.98492906 |
| 35 | Abnormality of T cell physiology (HP:0011840) | 2.98219451 |
| 36 | Increased cerebral lipofuscin (HP:0011813) | 2.94111225 |
| 37 | Increased IgE level (HP:0003212) | 2.91843713 |
| 38 | Abnormality of the nasal mucosa (HP:0000433) | 2.91823600 |
| 39 | Acute lymphatic leukemia (HP:0006721) | 2.87564539 |
| 40 | Type 2 muscle fiber atrophy (HP:0003554) | 2.85330642 |
| 41 | Muscle fiber atrophy (HP:0100295) | 2.84384973 |
| 42 | Macrocytic anemia (HP:0001972) | 2.82768339 |
| 43 | Recurrent bronchitis (HP:0002837) | 2.82295415 |
| 44 | Panhypogammaglobulinemia (HP:0003139) | 2.79323937 |
| 45 | Urticaria (HP:0001025) | 2.75785329 |
| 46 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.75753379 |
| 47 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.75753379 |
| 48 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.75381383 |
| 49 | Recurrent bacterial skin infections (HP:0005406) | 2.69434850 |
| 50 | Amaurosis fugax (HP:0100576) | 2.67622234 |
| 51 | Abnormality of glycolipid metabolism (HP:0010969) | 2.67603878 |
| 52 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.67603878 |
| 53 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.67603878 |
| 54 | Microcytic anemia (HP:0001935) | 2.65687342 |
| 55 | Acute myeloid leukemia (HP:0004808) | 2.62561920 |
| 56 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.62517847 |
| 57 | Gastrointestinal infarctions (HP:0005244) | 2.61884120 |
| 58 | Episodic fever (HP:0001954) | 2.61807863 |
| 59 | Autoimmune thrombocytopenia (HP:0001973) | 2.60622156 |
| 60 | Myelodysplasia (HP:0002863) | 2.60478505 |
| 61 | Gastrointestinal inflammation (HP:0004386) | 2.59859665 |
| 62 | Poikiloderma (HP:0001029) | 2.59515938 |
| 63 | Albinism (HP:0001022) | 2.56627295 |
| 64 | Abnormality of iron homeostasis (HP:0011031) | 2.55741855 |
| 65 | Gingivitis (HP:0000230) | 2.54981455 |
| 66 | Dysostosis multiplex (HP:0000943) | 2.54144796 |
| 67 | Keratoconjunctivitis sicca (HP:0001097) | 2.53909721 |
| 68 | Severe visual impairment (HP:0001141) | 2.51630089 |
| 69 | Hemoptysis (HP:0002105) | 2.51451890 |
| 70 | Inflammation of the large intestine (HP:0002037) | 2.50510536 |
| 71 | Hypothermia (HP:0002045) | 2.48371294 |
| 72 | Cellulitis (HP:0100658) | 2.47993443 |
| 73 | Hypochromic microcytic anemia (HP:0004840) | 2.47109955 |
| 74 | Granulocytopenia (HP:0001913) | 2.46405314 |
| 75 | Gingival bleeding (HP:0000225) | 2.46122345 |
| 76 | Leukocytosis (HP:0001974) | 2.45576994 |
| 77 | Purpura (HP:0000979) | 2.43298897 |
| 78 | Amyloidosis (HP:0011034) | 2.42059157 |
| 79 | Arterial thrombosis (HP:0004420) | 2.38953645 |
| 80 | Nasal polyposis (HP:0100582) | 2.38084351 |
| 81 | Spontaneous hematomas (HP:0007420) | 2.36674411 |
| 82 | Osteomyelitis (HP:0002754) | 2.36400224 |
| 83 | Recurrent viral infections (HP:0004429) | 2.36073555 |
| 84 | Pancytopenia (HP:0001876) | 2.35635170 |
| 85 | Asplenia (HP:0001746) | 2.33436673 |
| 86 | Meningitis (HP:0001287) | 2.30988604 |
| 87 | Keratoconjunctivitis (HP:0001096) | 2.30200532 |
| 88 | Erythema (HP:0010783) | 2.25664885 |
| 89 | Reticulocytosis (HP:0001923) | 2.25550538 |
| 90 | Hepatosplenomegaly (HP:0001433) | 2.24457294 |
| 91 | Pulmonary embolism (HP:0002204) | 2.24430591 |
| 92 | Lymphoma (HP:0002665) | 2.23183104 |
| 93 | Systemic lupus erythematosus (HP:0002725) | 2.21353767 |
| 94 | Vertigo (HP:0002321) | 2.21107908 |
| 95 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.21081692 |
| 96 | Pulmonary infiltrates (HP:0002113) | 2.19117401 |
| 97 | Increased IgM level (HP:0003496) | 2.19114086 |
| 98 | Interstitial pulmonary disease (HP:0006530) | 2.18051862 |
| 99 | Hypoproteinemia (HP:0003075) | 2.16620692 |
| 100 | Abnormality of macrophages (HP:0004311) | 2.16194936 |
| 101 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.16181232 |
| 102 | Hepatocellular necrosis (HP:0001404) | 2.16032470 |
| 103 | Agammaglobulinemia (HP:0004432) | 2.15416536 |
| 104 | Hypergammaglobulinemia (HP:0010702) | 2.14646882 |
| 105 | Loss of speech (HP:0002371) | 2.14177020 |
| 106 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.13418860 |
| 107 | Abnormality of the prostate (HP:0008775) | 2.13161053 |
| 108 | Gastrointestinal stroma tumor (HP:0100723) | 2.12553159 |
| 109 | Hypertensive crisis (HP:0100735) | 2.12527469 |
| 110 | Recurrent skin infections (HP:0001581) | 2.11555288 |
| 111 | Abnormality of the columella (HP:0009929) | 2.09823612 |
| 112 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.08154803 |
| 113 | IgG deficiency (HP:0004315) | 2.07865451 |
| 114 | Papilledema (HP:0001085) | 2.06407601 |
| 115 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 2.02906524 |
| 116 | Autoimmune hemolytic anemia (HP:0001890) | 2.02567323 |
| 117 | Paralysis (HP:0003470) | 2.02418993 |
| 118 | Abnormal platelet volume (HP:0011876) | 2.02358507 |
| 119 | Colon cancer (HP:0003003) | 2.01780162 |
| 120 | Abnormality of T cells (HP:0002843) | 2.01729906 |
| 121 | Hypochromic anemia (HP:0001931) | 2.01181446 |
| 122 | Thrombophlebitis (HP:0004418) | 2.01177410 |
| 123 | Recurrent fungal infections (HP:0002841) | 2.00336064 |
| 124 | Fatigue (HP:0012378) | 2.00303949 |
| 125 | Polygenic inheritance (HP:0010982) | 2.00010281 |
| 126 | B lymphocytopenia (HP:0010976) | 1.99820869 |
| 127 | Abnormality of B cell number (HP:0010975) | 1.99820869 |
| 128 | Thyroid-stimulating hormone excess (HP:0002925) | 1.99788047 |
| 129 | Disinhibition (HP:0000734) | 1.99029417 |
| 130 | Increased intramyocellular lipid droplets (HP:0012240) | 1.98969275 |
| 131 | Exertional dyspnea (HP:0002875) | 1.98959079 |
| 132 | Viral hepatitis (HP:0006562) | 1.98577183 |
| 133 | Chest pain (HP:0100749) | 1.98384572 |
| 134 | Abnormality of binocular vision (HP:0011514) | 1.96834140 |
| 135 | Diplopia (HP:0000651) | 1.96834140 |
| 136 | Increased serum ferritin (HP:0003281) | 1.96289991 |
| 137 | Colitis (HP:0002583) | 1.95938582 |
| 138 | Nonprogressive disorder (HP:0003680) | 1.95604791 |
| 139 | Abnormality of the peritoneum (HP:0002585) | 1.95182645 |
| 140 | Skin rash (HP:0000988) | 1.92755428 |
| 141 | Lymphopenia (HP:0001888) | 1.92577478 |
| 142 | Hematochezia (HP:0002573) | 1.91420260 |
| 143 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.89771783 |
| 144 | Menorrhagia (HP:0000132) | 1.89526505 |
| 145 | Increased muscle lipid content (HP:0009058) | 1.87060203 |
| 146 | Migraine (HP:0002076) | 1.85096701 |
| 147 | Neutropenia (HP:0001875) | 1.83906502 |
| 148 | Thoracic kyphosis (HP:0002942) | 1.83617957 |
| 149 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.83065652 |
| 150 | Orchitis (HP:0100796) | 1.82207744 |
| 151 | Mediastinal lymphadenopathy (HP:0100721) | 1.81895321 |
| 152 | Pulmonary fibrosis (HP:0002206) | 1.80603169 |
| 153 | Hepatic necrosis (HP:0002605) | 1.80549486 |
| 154 | Chronic sinusitis (HP:0011109) | 1.79073431 |
| 155 | Vacuolated lymphocytes (HP:0001922) | 1.77747553 |
| 156 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.77291084 |
| 157 | Vasculitis (HP:0002633) | 1.77262018 |
| 158 | Abnormality of reticulocytes (HP:0004312) | 1.76925303 |
| 159 | Bruising susceptibility (HP:0000978) | 1.76830028 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | KIT | 3.49658688 |
| 2 | TNIK | 3.42116436 |
| 3 | FLT3 | 2.99469403 |
| 4 | NME2 | 2.82557302 |
| 5 | STK16 | 2.77686292 |
| 6 | TGFBR1 | 2.68074841 |
| 7 | WEE1 | 2.61851615 |
| 8 | PRPF4B | 2.60688526 |
| 9 | MAP4K1 | 2.53390069 |
| 10 | CDK19 | 2.53272506 |
| 11 | EEF2K | 2.43243674 |
| 12 | TGFBR2 | 2.36339150 |
| 13 | MUSK | 2.30753922 |
| 14 | BTK | 2.30281820 |
| 15 | TEC | 2.23488145 |
| 16 | TIE1 | 2.07203661 |
| 17 | CSF1R | 2.05688106 |
| 18 | CSK | 1.90279558 |
| 19 | ACVR1B | 1.90239123 |
| 20 | MAP3K14 | 1.88653092 |
| 21 | MATK | 1.87663775 |
| 22 | MAP2K3 | 1.84856696 |
| 23 | PIM2 | 1.78236387 |
| 24 | JAK3 | 1.64895812 |
| 25 | RPS6KB2 | 1.50160979 |
| 26 | BRSK2 | 1.49849880 |
| 27 | VRK1 | 1.45808506 |
| 28 | BMPR2 | 1.43883930 |
| 29 | MAPKAPK5 | 1.42953485 |
| 30 | MAP3K1 | 1.41265253 |
| 31 | MAP3K13 | 1.40330178 |
| 32 | MAP3K12 | 1.40238873 |
| 33 | SYK | 1.40033512 |
| 34 | DYRK3 | 1.36662209 |
| 35 | TBK1 | 1.29462185 |
| 36 | SCYL2 | 1.28882130 |
| 37 | ZAP70 | 1.26305247 |
| 38 | CAMKK2 | 1.26140350 |
| 39 | MAP3K3 | 1.23311111 |
| 40 | FES | 1.21762208 |
| 41 | MKNK1 | 1.21424029 |
| 42 | IRAK4 | 1.19906050 |
| 43 | KDR | 1.15782523 |
| 44 | NLK | 1.14146756 |
| 45 | MAPK12 | 1.11920556 |
| 46 | TAOK2 | 1.11545861 |
| 47 | MAPKAPK3 | 1.10257649 |
| 48 | IKBKB | 1.09813524 |
| 49 | PIM1 | 1.08073353 |
| 50 | IKBKE | 1.06306661 |
| 51 | TYK2 | 1.03948827 |
| 52 | MAP3K6 | 1.02200895 |
| 53 | ITK | 1.01641372 |
| 54 | CDK8 | 0.99131222 |
| 55 | LRRK2 | 0.98593331 |
| 56 | LYN | 0.96991296 |
| 57 | IRAK1 | 0.95859860 |
| 58 | IRAK2 | 0.95026083 |
| 59 | BCKDK | 0.93454650 |
| 60 | CCNB1 | 0.92925754 |
| 61 | TAOK3 | 0.92296870 |
| 62 | MARK2 | 0.88439687 |
| 63 | DAPK2 | 0.87985263 |
| 64 | FGR | 0.87122645 |
| 65 | TAOK1 | 0.85112443 |
| 66 | PRKG2 | 0.84909247 |
| 67 | PKN2 | 0.83837783 |
| 68 | ADRBK2 | 0.82095325 |
| 69 | LCK | 0.81465969 |
| 70 | JAK1 | 0.78893684 |
| 71 | MAP2K6 | 0.77195953 |
| 72 | MAPK4 | 0.76626797 |
| 73 | MAP3K11 | 0.75957133 |
| 74 | CAMK1 | 0.75382595 |
| 75 | NEK2 | 0.75210196 |
| 76 | BUB1 | 0.75131936 |
| 77 | MARK3 | 0.75080000 |
| 78 | CDK7 | 0.74741559 |
| 79 | CDC7 | 0.73923628 |
| 80 | MAPK7 | 0.73699582 |
| 81 | TXK | 0.73183880 |
| 82 | PIK3CG | 0.72884710 |
| 83 | BLK | 0.72660386 |
| 84 | TESK2 | 0.72031027 |
| 85 | PRKCQ | 0.71541025 |
| 86 | MKNK2 | 0.71178479 |
| 87 | DAPK1 | 0.68318769 |
| 88 | EIF2AK3 | 0.66622580 |
| 89 | HIPK2 | 0.66415433 |
| 90 | MAP3K7 | 0.65521815 |
| 91 | ERN1 | 0.64527635 |
| 92 | PDK1 | 0.64310785 |
| 93 | CDK4 | 0.64209972 |
| 94 | PASK | 0.63918957 |
| 95 | MAPK11 | 0.59421190 |
| 96 | RPS6KA4 | 0.58645948 |
| 97 | MAP2K4 | 0.58290274 |
| 98 | PAK4 | 0.58074616 |
| 99 | ATR | 0.57795522 |
| 100 | HCK | 0.56363149 |
| 101 | EIF2AK1 | 0.56333845 |
| 102 | YES1 | 0.54923143 |
| 103 | PDPK1 | 0.54227368 |
| 104 | RAF1 | 0.53249937 |
| 105 | MAP3K5 | 0.52799192 |
| 106 | TNK2 | 0.51848146 |
| 107 | TLK1 | 0.48623648 |
| 108 | RPS6KA6 | 0.47862464 |
| 109 | STK10 | 0.47585099 |
| 110 | MAP2K2 | 0.47314269 |
| 111 | RIPK4 | 0.47313653 |
| 112 | MYLK | 0.46803828 |
| 113 | BRSK1 | 0.46756593 |
| 114 | DYRK1B | 0.45581284 |
| 115 | MAPK15 | 0.44940913 |
| 116 | STK4 | 0.44366272 |
| 117 | CDK6 | 0.41539786 |
| 118 | EPHB1 | 0.41101768 |
| 119 | KSR2 | 0.39525940 |
| 120 | TSSK6 | 0.39465935 |
| 121 | FYN | 0.38869239 |
| 122 | RPS6KA2 | 0.37980198 |
| 123 | RPS6KL1 | 0.37834100 |
| 124 | RPS6KC1 | 0.37834100 |
| 125 | ABL2 | 0.36634901 |
| 126 | GRK6 | 0.35297720 |
| 127 | SIK2 | 0.34654179 |
| 128 | PRKCD | 0.33935936 |
| 129 | AURKB | 0.33806538 |
| 130 | IRAK3 | 0.33570618 |
| 131 | JAK2 | 0.33545044 |
| 132 | RET | 0.33258179 |
| 133 | CLK1 | 0.32345104 |
| 134 | ABL1 | 0.32300313 |
| 135 | SGK2 | 0.31086239 |
| 136 | EIF2AK2 | 0.31000555 |
| 137 | GRK7 | 0.30708983 |
| 138 | NEK9 | 0.30402092 |
| 139 | TRPM7 | 0.30372954 |
| 140 | MAPK3 | 0.30274317 |
| 141 | SGK3 | 0.28661024 |
| 142 | PRKD2 | 0.27961597 |
| 143 | STK11 | 0.25382502 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 5.07819499 |
| 2 | DNA replication_Homo sapiens_hsa03030 | 4.61620283 |
| 3 | Mismatch repair_Homo sapiens_hsa03430 | 3.45547861 |
| 4 | Base excision repair_Homo sapiens_hsa03410 | 2.86288167 |
| 5 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 2.80738140 |
| 6 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.57476873 |
| 7 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.30881599 |
| 8 | Homologous recombination_Homo sapiens_hsa03440 | 2.29070265 |
| 9 | Spliceosome_Homo sapiens_hsa03040 | 2.13879605 |
| 10 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.11943059 |
| 11 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.07689118 |
| 12 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.05692543 |
| 13 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.95046368 |
| 14 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.91085675 |
| 15 | RNA polymerase_Homo sapiens_hsa03020 | 1.81916672 |
| 16 | Sulfur relay system_Homo sapiens_hsa04122 | 1.79546216 |
| 17 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.66853574 |
| 18 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.61889166 |
| 19 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.61177686 |
| 20 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.60601826 |
| 21 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.59995850 |
| 22 | Other glycan degradation_Homo sapiens_hsa00511 | 1.56639450 |
| 23 | Leishmaniasis_Homo sapiens_hsa05140 | 1.55130752 |
| 24 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.53933342 |
| 25 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.50797674 |
| 26 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.49575911 |
| 27 | * Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.40375543 |
| 28 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.39025160 |
| 29 | Measles_Homo sapiens_hsa05162 | 1.38860598 |
| 30 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.38320094 |
| 31 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.37664667 |
| 32 | Proteasome_Homo sapiens_hsa03050 | 1.36538386 |
| 33 | RNA degradation_Homo sapiens_hsa03018 | 1.32778716 |
| 34 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.31001767 |
| 35 | Cell cycle_Homo sapiens_hsa04110 | 1.29726007 |
| 36 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.25254021 |
| 37 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.24785061 |
| 38 | Platelet activation_Homo sapiens_hsa04611 | 1.22747403 |
| 39 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.21542759 |
| 40 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.19913413 |
| 41 | Phagosome_Homo sapiens_hsa04145 | 1.19650742 |
| 42 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.19426418 |
| 43 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.18278992 |
| 44 | Lysosome_Homo sapiens_hsa04142 | 1.17993680 |
| 45 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.17367126 |
| 46 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.15088110 |
| 47 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.14214369 |
| 48 | Shigellosis_Homo sapiens_hsa05131 | 1.10398295 |
| 49 | Purine metabolism_Homo sapiens_hsa00230 | 1.10363073 |
| 50 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.09879819 |
| 51 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.08502197 |
| 52 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.03059806 |
| 53 | Viral myocarditis_Homo sapiens_hsa05416 | 1.02963696 |
| 54 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.98131495 |
| 55 | Thyroid cancer_Homo sapiens_hsa05216 | 0.97035863 |
| 56 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.97000904 |
| 57 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.95625979 |
| 58 | Basal transcription factors_Homo sapiens_hsa03022 | 0.95581394 |
| 59 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.95003495 |
| 60 | RNA transport_Homo sapiens_hsa03013 | 0.92025337 |
| 61 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.92020859 |
| 62 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.91080303 |
| 63 | Legionellosis_Homo sapiens_hsa05134 | 0.88416477 |
| 64 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.88282409 |
| 65 | Protein export_Homo sapiens_hsa03060 | 0.87861506 |
| 66 | Hepatitis B_Homo sapiens_hsa05161 | 0.86334285 |
| 67 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.86037999 |
| 68 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.85895044 |
| 69 | Pertussis_Homo sapiens_hsa05133 | 0.84322154 |
| 70 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.82495752 |
| 71 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.80914314 |
| 72 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.80471476 |
| 73 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.80399303 |
| 74 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.80266627 |
| 75 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.80040798 |
| 76 | Influenza A_Homo sapiens_hsa05164 | 0.79685175 |
| 77 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.78522025 |
| 78 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.78043583 |
| 79 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.77362391 |
| 80 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.76364387 |
| 81 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.75085119 |
| 82 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.74961295 |
| 83 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.73256247 |
| 84 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.71752676 |
| 85 | Apoptosis_Homo sapiens_hsa04210 | 0.71638969 |
| 86 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.71450781 |
| 87 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.70222685 |
| 88 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.69130199 |
| 89 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.68715288 |
| 90 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.67665095 |
| 91 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.66811047 |
| 92 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.66669436 |
| 93 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.66465618 |
| 94 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.66392205 |
| 95 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.66322858 |
| 96 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.65221061 |
| 97 | Amoebiasis_Homo sapiens_hsa05146 | 0.64781640 |
| 98 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.64636636 |
| 99 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.64216792 |
| 100 | Malaria_Homo sapiens_hsa05144 | 0.62816037 |
| 101 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.61065299 |
| 102 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.60471228 |
| 103 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.59337440 |
| 104 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.58754557 |
| 105 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.58254839 |
| 106 | Galactose metabolism_Homo sapiens_hsa00052 | 0.57883394 |
| 107 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.57481476 |
| 108 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.55275693 |
| 109 | Endocytosis_Homo sapiens_hsa04144 | 0.54754686 |
| 110 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.54497869 |
| 111 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.53845533 |
| 112 | Salmonella infection_Homo sapiens_hsa05132 | 0.52865441 |
| 113 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.52769244 |
| 114 | Prion diseases_Homo sapiens_hsa05020 | 0.52582614 |
| 115 | Tuberculosis_Homo sapiens_hsa05152 | 0.52432581 |
| 116 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.50771140 |
| 117 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.49381184 |
| 118 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.48771582 |
| 119 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.48233485 |
| 120 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.46400421 |
| 121 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.44818651 |
| 122 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.44248084 |
| 123 | Allograft rejection_Homo sapiens_hsa05330 | 0.42737739 |
| 124 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.41225213 |
| 125 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.40676415 |
| 126 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.40422908 |
| 127 | HTLV-I infection_Homo sapiens_hsa05166 | 0.40158653 |
| 128 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.39843380 |
| 129 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.39740540 |
| 130 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.38818151 |
| 131 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.37282136 |
| 132 | ABC transporters_Homo sapiens_hsa02010 | 0.36860260 |
| 133 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.36616473 |
| 134 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.36516485 |
| 135 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.36061327 |
| 136 | Alcoholism_Homo sapiens_hsa05034 | 0.35215193 |
| 137 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.34817491 |
| 138 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.34675162 |
| 139 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.34213781 |
| 140 | Renin secretion_Homo sapiens_hsa04924 | 0.33946868 |
| 141 | Asthma_Homo sapiens_hsa05310 | 0.33777037 |
| 142 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.32731106 |
| 143 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.32631828 |
| 144 | Insulin resistance_Homo sapiens_hsa04931 | 0.31868076 |
| 145 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.30197532 |
| 146 | Hepatitis C_Homo sapiens_hsa05160 | 0.29807980 |

